In addition, studies on the relationship between PD-L1 expression and the disease outcomes have shown that PD-L1 expression significantly correlates with poor prognosis in kidney, ovarian, bladder, breast, liver, gastric, and pancreatic cancer [8]. The gene discussed is CD274; the disease is pancreatic neoplasm.